Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CC
CC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CC News
Chemours Options Contract Analysis and Investment Opportunities
3d ago
NASDAQ.COM
Chemours Company to Release Q4 2025 Financial Results on February 19, 2026
Feb 04 2026
PRnewswire
Chemours (CC) Sells Taiwan Land for $360 Million Cash
Jan 16 2026
seekingalpha
Chemours Sells Taiwan Titanium Site for $360 Million Cash
Jan 15 2026
PRnewswire
Chemours Sells Taiwan Titanium Site for $360 Million Cash
Jan 15 2026
Newsfilter
IBM and LXEO Options Show Significant Volume Surge
Jan 09 2026
NASDAQ.COM
Alta Fundamental Advisers Acquires 800,000 Shares of Chemours Worth $12.67 Million
Dec 22 2025
Fool
Positive Cross of the 200-Day Moving Average - CC
Dec 05 2025
NASDAQ.COM
Chemours Appoints Michael Foley as President of Titanium Technologies Effective February 2026
Dec 04 2025
Newsfilter
DuPont Poised for Growth: Why the Stock May Rise by 20%.
Nov 25 2025
Barron's
Deutsche Bank Recommends Buying DuPont Stock, Predicting It Could Evolve into a 'Compounder.'
Nov 25 2025
Barron's
UBS Reiterates Buy Rating for Chemours, Adjusts Price Target to $18
Nov 11 2025
Benzinga
Chemours Q3 Earnings Fall Short of Expectations Due to Operational Challenges
Nov 11 2025
NASDAQ.COM
Chemours Projects Double-Digit Growth for Opteon and $5.7B–$5.8B in Sales by 2025 as TSS Segment Exceeds Expectations
Nov 07 2025
SeekingAlpha
Three Materials Stocks Set to Surge in Q4
Nov 07 2025
Benzinga
Chemours (CC) Releases Q3 Earnings: Insights from Key Metrics
Nov 07 2025
NASDAQ.COM
Show More News
